Skip to main content
SpringerLink
Log in

Cytochrome Oxidase Inhibition In Alzheimer’s Disease

  • Chapter
Cytochrome Oxidase in Neuronal Metabolism and Alzheimer’s Disease

Abstract

There is a compelling need to understand neuronal oxidative metabolism in Alzheimer’s brains in order to unequivocally diagnose and treat Alzheimer’s disease patients successfully. This disease may be affecting one of every three families in the US. Although rare familial types of Alzheimer’s disease follow Mendelian genetics, most cases appear after age 65 and have no clearly identifiable nuclear genetic defects. It is in this majority of late-onset, sporadic cases that defects in cytochrome oxidase activity have been linked to mitochondrial DNA mutations. Recent mounting evidence suggests that a cytochrome oxidase catalytic defect with mitochondrial DNA oxidative damage is a reliable marker of sporadic Alzheimer’s disease. With advancing age, chronic inhibition of cytochrome oxidase activity produces neuronal metabolic failure and memory dysfunction. Cytochrome oxidase inhibition leads to senile dementia and neurodegeneration in late-onset Alzheimer’s disease in a cascade of multiple intracellular events, initiated primarily by neuronal aerobic energy depletion, mitochondrial formation of reactive oxygen species and disruption of intracellular calcium homeostasis. Quantitative cytochemical methods for assessing cytochrome oxidase activity in individual cells are described in detail. Cytochemical findings are discussed in relationship to the selective vulnerability of metabolically active larger projection neurons in Alzheimer’s brains. Additional results are presented that suggest that muscle biopsy may be used as an early diagnostic aid in living subjects suspected of sporadic Alzheimer’s disease. The data support the hypothesis that sporadic Alzheimer’s disease is a systemic mitochondrial disease, characterized by cytochrome oxidase inhibition. Early in sporadic Alzheimer’s disease the inhibition of neuronal cytochrome oxidase activity is caused by a systemic cytochrome oxidase defect. The brain is proposed to be the most vulnerable organ to show primary oxidative pathogenesis as a result of systemic cytochrome oxidase inhibition. Possible treatments for neuronal oxidative stress in Alzheimer’s disease are proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aggleton, J.P. (Ed.), 1992, The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. New York: Wiley-Liss.

    Google Scholar 

  • Akaaboune, M., Villanova, M., Festoff, B.W., Verdiere-Sahuque, M., & Hantai, D., 1994, Apolipoprotein E expression at neuromuscular junctions in mouse, rat and human skeletal muscle, FEBS Letters, 351, 246–248.

    Article  PubMed  CAS  Google Scholar 

  • Arai, H., 1996, Biological markers for the clinical diagnosis of Alzheimer’s disease. Tohoku Journal ofExperimental Medicine, 179, 65–79.

    Article  CAS  Google Scholar 

  • Arendt, T., Bigl, V., Arendt, A., & Tennstedt, A., 1983, Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans and Korsakoff’s disease. Acta Neuropathologica, 61, 101–108.

    Article  PubMed  CAS  Google Scholar 

  • Ball, M.J., Fisman, M., Hachinski, V., Blume, W., Fox, A., Kral, V.A., Kirshen, A.J., Fox, H., & Merskey, H.,1985, A new definition of Alzheimer’s disease: A hippocampal dementia. Lancet, 1, 14–16.

    Google Scholar 

  • Bauserman, S.C. & Heffner, R.R., 1984, Mitochondrial myopathies. In Heffner, R.R. (Ed.), Muscle Pathology, L.W. Roth, Series Ed., Churchill-Livingstone, Inc., New York.

    Google Scholar 

  • Beal, M.F., 1992a, Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Annals of Neurology, 31, 119–130.

    Article  PubMed  CAS  Google Scholar 

  • Beal, M.F., 1992b, Mechanisms of excitotoxicity in neurologic diseases. The FASEB Journal, 6, 3338–3342.

    CAS  Google Scholar 

  • Beal, M.F.; Howell, N.; Bodis-Wollner, I. (Eds.), 1997, Mitochondria and Free Radicals in Neurodegenerative Diseases. New York: Wiley-Liss.

    Google Scholar 

  • Beal, M.F., Hyman, B.T., & Koroshetz, W., 1993, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative disorders? Trends in Neurosciences, 16, 125–131.

    Article  PubMed  CAS  Google Scholar 

  • Becker. W., Reece, J.B., & Peonie, M.F., 1996, The World of the Cell. Menlo Park: Benjamin/Cummings Publishing Company.

    Google Scholar 

  • Behl, C., Davis, J., Cole, G.M., & Schubert, D., 1992, Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochemical and Biophysical Research Communications, 186, 944–950.

    Google Scholar 

  • Behl, C., Widmann, M., Trapp, T., & Holsboer, F., 1995, 17-beta estradiol protects neurons from oxidative stressinduced cell death in vitro. Biochemical and Biophysical Research Communications, 216, 473–482.

    Google Scholar 

  • Behl, C., Trapp, T., Skutella. T., & Holsboer, F., 1997, Protection against oxidative stress-induced neuronal cell death-a novel role for RU486. European Journal of Neuroscience, 9,9I2–920.

    Google Scholar 

  • Betel, C., Skutella, T., Lezoualc’h, F., Post, A., Widmann, M., Newton, C.J., & Holsboer, F., 1997, Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Molecular Pharmacology, 51, 535–541.

    Google Scholar 

  • Bennett, M.C., & Rose, G.M., 1992, Chronic sodium azide treatment impairs learning of the Morris water maze task. Behavioral and Neural Biology, 58, 72–75.

    Article  PubMed  CAS  Google Scholar 

  • Bennett, M.C., Diamond, D.M., Parker, W.D., Jr., Stryker, S.L., & Rose, G.M., 1992a, Inhibition of cytochrome oxidase impairs learning and hippocampal plasticity: a novel animal model of Alzheimer’s disease. In J. Simpkins, F.T. Crews, & E.M. Meyer (Eds.), Alzheimer’s Disease Therapy: A New Generation of Progress, pp. 485–501, New York: Plenum Press.

    Google Scholar 

  • Bennett, M.C., Diamond, D.M., Stryker, S.L., Parks, J.K., & Parker, W.D., Jr., 1992b, Cytochrome oxidase inhibition: a novel animal model of Alzheimer’s disease. Journal of Geriatric Psychiatry and Neurology, 5, 93–101.

    PubMed  CAS  Google Scholar 

  • Biegon, A., & Wolff, M., 1986, Quantitative histochemistry of acetylcholinesterase in rat and human brain postmortem. Journal of Neuroscience Methods, 16, 39–45.

    Article  PubMed  CAS  Google Scholar 

  • Blass, J.P., Sheu, R.K.F., & Cedarbaum, J.M., 1988, Energy metabolism in disorders of the nervous system. Revue Neurologique, 144, 543–563.

    PubMed  CAS  Google Scholar 

  • Blass, J.P., 1993, Metabolic alterations common to neural and non-neural cells in Alzheimer’s disease. Hippocampus, 3 Spec No, 45–53.

    Google Scholar 

  • Bloch, V., 1976, Brain activation and memory consolidation. In M.R. Rosenzweig & E.L. Bennett (Eds.), Neural Mechanisms of Learning and Memory, pp. 582–590, Cambridge, Massachusetts: MIT Press.

    Google Scholar 

  • Boveris, A., & Chance, B., 1973, The mitochondrial generation of hydrogen peroxide: General properties and the effect of hyperbaric oxygen. Biochemical Journal, 134, 707–716.

    PubMed  CAS  Google Scholar 

  • Cada, A.. Gonzalez-Lima, F., Rose, G.M., & Bennett, M.C., 1995, Regional brain effects of sodium azide treatment on cytochrome oxidase activity: A quantitative histochemical study. Metabolic Brain Disease, 10, 303–319.

    CAS  Google Scholar 

  • Carney, J.M., & Floyd, R.A., 1991, Protection against oxidative damage to CNS by alpha-phenyl-tert-butyl nitrone, PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers. Journal of Molecular Neuroscience, 3, 47–57.

    Article  PubMed  CAS  Google Scholar 

  • Chagnon, P., Betard, C., Robitaille, Y., Cholette, A.. Gauvreau, & D., 1995, Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport, 6, 711–715.

    Article  PubMed  CAS  Google Scholar 

  • Chandrasekaran, K., Stoll, J.. Giordano, T., Atack, J.R., Matocha, M.F., Brady, D.R., & Rapoport, S.I., 1992, Differential expression of cytochrome oxidase, COX) genes in different regions of monkey brain. Journal of Neuroscience Research, 32, 41 5–423.

    Google Scholar 

  • Chandrasekaran, K., Giordano, T., Brady, D.R., Stoll, J., Martin, L.J., & Rapoport, S.I., 1994, Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer’s disease. Molecular Brain Research, 24, 336–340.

    Article  PubMed  CAS  Google Scholar 

  • Coomber, P., Crews, D., & Gonzalez-Lima, F., 1997, Independent effects of incubation temperature and gonadal sex on the volume and metabolic capacity of brain nuclei in the leopard gecko, Eublepharismacularius), a lizard with temperature-dependent sex determination. Journal of Comparative Neurology, 380, 409–421.

    Article  PubMed  CAS  Google Scholar 

  • Curti, D., Giangare, M.C., Redolfi, M.E., Fugaccia, I., & Benzi, G., 1990, Age-related modifications of cytochrome r oxidase activity in discrete brain regions. Mechanisms of Ageing and Development, 55, 171–180.

    Article  PubMed  CAS  Google Scholar 

  • Davis, R.E., Miller, S., Herrnstadt, C., Ghosh, S.S., Fahy, E., Shinobu, L.A., Galasko, D., Thal, L.J., Beal, M.F., Howell, N., and Parker, W.D., 1997, Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proceedings of the National Academy of Sciences, 94, 4526–4531.

    Article  CAS  Google Scholar 

  • de la Torre, J.C., Cada, A., Nelson, N., Davis, G., Sutherland, R.J., & Gonzalez-Lima, F., 1997, Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats. Neuroscience Letters, 223, 165–168.

    Article  PubMed  Google Scholar 

  • de Leon, M.J., Convit, A., George, A.E., Golomb, J., de Santi, S., Tarshish, C., Rusinek, H., Bobinski, M., Ince, C., Miller, D., & Wisniewski, H., 1996, In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer’s disease. Annals of the New York Academy of Sciences,777,1–13.

    Google Scholar 

  • Dykens, J.A., 1997, Mitochondrial free radical production and oxidative pathophysiology: implications for neurodegenerative diseases. In M.F. Beal, N. Howell, & I. Bodis-Wollner (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases, pp. 29–56, New York: Wiley-Liss.

    Google Scholar 

  • Gabbita, S.P., Butterfield D.A., & Carney, J.M., 1997, Neurodegeneration and potential antioxidant-based therapeutic approaches. In M.F. Beal, N. Howell, & I. Bodis-Wollner (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases, pp. 497–512, New York: Wiley-Liss.

    Google Scholar 

  • Gonzalez-Lima, E.M., & Gonzalez-Lima, F., 1987, Sources of stress affecting caregivers of Alzheimer’s disease patients. Health Values, 1l, 3–10.

    Google Scholar 

  • Gonzalez-Lima, F., & Scheich, H., 1985, Ascending reticular activating system in the rat: A 2- deoxyglucose study. Brain Research, 344, 70–88.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez-Lima, F., & Garrosa, M., 1991, Quantitative histochemistry of cytochrome oxidase in rat brain. Neuroscience Letters, 123, 251–253.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez-Lima, F., 1992, Brain imaging of auditory learning functions in rats: Studies with fluorodeoxyglucose autoradiography and cytochrome oxidase histochemistry. In F. Gonzalez-Lima, T. Finkenstadt, & H. Scheich (Eds.), Advances in Metabolic Mapping Techniques for Brain Imaging of Behavioral and Learning Functions, NATO ASI Vol. D68, pp. 39–109, The Netherlands: Kluwer Academic Publishers.

    Google Scholar 

  • Gonzalez-Lima, F., Helmstetter, F.J., & Agudo,.1., 1993, Functional mapping of the rat brain during drinking behavior: A fluorodeoxyglucose study. Physiology and Behavior, 54, 605–612.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez-Lima, F., & Jones, D., 1994, Quantitative mapping of cytochrome oxidase activity in the central auditory system of the gerbil: A study with calibrated activity standards and metal-intensified histochemistry. Brain Research, 660, 34–49.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez-Lima, F., & Cada, A., 1994, Cytochrome oxidase activity in the auditory system of the mouse: A qualitative and quantitative histochemical study. Neuroscience, 63, 559–578.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez-Lima, F., & McIntosh, A.R., 1996, Conceptual and methodological issues in the interpretation of brain-behavior relationships. In R.W. Thatcher, G.R. Lyon, J. Ramsey, & N. Krasnegor (Eds.), Developmental Neuroimaging: Mapping the Development of Brain and Behavior; pp. 235–253, Orlando, Florida: Academic Press.

    Google Scholar 

  • Gonzalez-Lima, F., Valla, J., and Matos-Collazo, S., 1997, Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer’s patients. Brain Research, 752, 117–126.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez-Lima, F., Valla, J., & Cada, A., 1998, Brain cytochrome oxidase activity and how it relates to the pathophysiology of memory and Alzheimer’s disease. In T. Ozben (Ed.), Free Radicals, Oxidative Stress and Antioxidants: Pathological and Physiological Significance. New York: Plenum Press.

    Google Scholar 

  • Grimes, A.M., Grady, C.L., Foster, N.L., Sunderland, T.. & Patronas, N.J., 1985. Central auditory function in Alzheimer’s disease. Neurology, 35, 352–358.

    Article  PubMed  CAS  Google Scholar 

  • Gunther, T.E., & Pfeiffer, D.R., 1990, Mechanisms by which mitochondria transport calcium. ArnericanJournal of Physiology, 258, c755 - c786

    Google Scholar 

  • Harman, D., 1988, Free radicals in aging. Molecular and Cellular Biochemistry, 84, 155–161.

    Article  PubMed  CAS  Google Scholar 

  • Henderson, V.W., 1997, The epidemiology of estrogen replacement therapy and Alzheimer’s disease. Neurology’, 48, S27 - S35

    Article  PubMed  CAS  Google Scholar 

  • Hensley, K., Carney, J.M., Stewart, C.A., Tabatabaie, T., Pye, Q., & Floyd, R.A., 1997, Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies. international Review of Neurobiology, 40, 299–317.

    Article  PubMed  CAS  Google Scholar 

  • Hess, H.H., & Pope, A., 1953, Ultramicrospectrophotometric determination of cytochrome oxidase for quantitative histochemistry. Journal of Biological Chemistry, 209, 295–306.

    Google Scholar 

  • Hevner, R.F., & Wong-Riley, M.T.T., 1989, Brain cytochrome oxidase: purification, antibody production, and immunohistochemical/histochemical correlations in the CNS. Jounal of Neuroscience, 9, 3884–3898.

    CAS  Google Scholar 

  • Hevner, R.F., Duff, R.S., & Wong-Riley, M.T.T., 1992, Coordination of ATP production and consumption in brain: parallel regulation of cytochrome oxidase and NA+, K+-ATPase. Neuroscience Letters, 138, 188–192.

    Google Scholar 

  • Hevner, R.F., Liu, S., & Wong-Riley, M.T.T., 1993, An optimized method for determining cytochrome oxidase activity in brain tissue homogenates. Journal of Neuroscience Methods, 50, 309–319.

    Article  PubMed  CAS  Google Scholar 

  • Huidobro, A., Blanco, P., Villalba, M., Gomez-Puertas, P., Villa, A., Pereira, R., Bogonez, E., Martinez-Serrano, A., Aparicio, J.J., & Satrustegui, J., 1993, Age-related changes in calcium homeostatic mechanisms in synaptosomes in relation with working memory deficiency. Neurobiology of Aging. 14, 479–486.

    Article  PubMed  CAS  Google Scholar 

  • Ihara, Y., 1988, Massive somatodendritic sprouting of cortical neurons in Alzheimer’s disease. Brain Research, 459, 138–144.

    Article  PubMed  CAS  Google Scholar 

  • Iwamoto, N., Thangnipon, W., Crawford, C., & Emson, P.C., 1991, Localization of calpain immunoreactivity in senile plaques and in neurones undergoing neurofibrillary degeneration in Alzheimer’s disease. Brain Research, 561, 177–180.

    Article  PubMed  CAS  Google Scholar 

  • Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R.. Corrada, M.. Zonderman, A., Bacal, C., Lingle, D.D., & Metter, E., 1997, A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology, 48, 1517–1521.

    CAS  Google Scholar 

  • Kish, S.J., Bergeron, C’., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J.M., DiStefano, L.M., & Nobrega, J.N., 1992, Brain cytochrome oxidase in Alzheimer’s disease. Journal of Neurochemistr v, 59, 776–779.

    CAS  Google Scholar 

  • Kish, S.J., 1997, Brain energy metabolizing enzymes in Alzheimer’s disease: alpha-ketoglutarate dehydrogenase complex and cytochrome oxidase. In J.C. de la Torre and V. Hachinski (Eds.), Cerebrovaxciilar Pathology in A1=heinters Disease, pp. 218 228, New York: New York Academy of Sciences.

    Google Scholar 

  • Landin, K., Blennow, K., Wallin, A., & Gottfries, C.G., 1993, Low blood pressure and blood glucose levels in Alzheimer’s disease: Evidence for a hypometabolic disorder ? Journal of Internal Medicine, 233, 257–363.

    Google Scholar 

  • Lowry, O.H., Rosebrough, N.J., Farr, A.L., & Randall, R.J., 1951. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 295–275.

    Google Scholar 

  • Maurizi, C.P., 1997, Loss of intraventricular fluid melatonin can explain the neuropathology of Alzheimer’s disease. Medical Hypotheses., 49, 153–158.

    Google Scholar 

  • McEwen, B.S., Alves, S.E., Bulloch, K., & Weiland, N.G., 1997, Ovarian steroids and the brain: implications for cognition and aging. Neurology, 48, S8 - S15

    Article  PubMed  CAS  Google Scholar 

  • Mecocci, P., MacGarvey, U., & Beal, M.F., 1994, Oxidative damage to mitochondria) DNA is increased in Alzheimer’s disease. Annals ofNeurology, 36, 747–751.

    Google Scholar 

  • Meier-Ruge, W., Bertoni-Freddari, C., & Iwangoff, P., 1994, Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer’s disease. Gerontology, 40, 246–252.

    Google Scholar 

  • Meier-Ruge, W.A., and Bertoni-Freddari, C., 1997, Pathogenesis of decreased glucose turnover and oxidative phosphorylation in ischemic and trauma-induced dementia of the Alzheimer type. In J.C. de la Torre and V. Hachinski (Eds.), Cerebrovaseular Pathology in Alzheimer’s Disease, pp. 229–241, New York: New York Academy of Sciences.

    Google Scholar 

  • Mutisya, E.M., Bowling, A.C., & Beal, M.F., 1994, Cortical cytochrome oxidase activity is reduced in Alzheimer’s disease. Journal of Neurochemistry, 63, 2179–2184.

    Article  PubMed  CAS  Google Scholar 

  • Nicotera, P., Bellomo, G., & Orrenius. S., 1990, The role ofCa2+ in cell killing. Chemical Research in Toxicology, 3, 484–494.

    Google Scholar 

  • Nixon, R.A., & Cataldo, A.M.. 1994, Free radicals, proteolysis, and the degeneration of neurons in Alzheimer disease: How essential is the b-amyloid link? Neurobiology of Aging, 15, 463–469.

    Article  CAS  Google Scholar 

  • Nobrega, J.N., 1992, Brain metabolic mapping and behavior: Assessing the effects of early developmental experiences in adult animals. In F. Gonzalez-Lima, T. Finkenstaedt, & H. Scheich (Eds.), Advances in Metabolic Mapping Techniques for Brain Imaging of Behavioral and Learning Functions, NATO ASI Vol. D68, pp. 125–149, Dordrecht/Boston/London: Kluwer Academic Publishers.

    Google Scholar 

  • Nobrega, J.N., Raymond. R., DiStefano, L., & Burnham, W.M., 1993, Long-term changes in regional brain cytochrome oxidase activity induced by electroconvulsive treatment in rats. Brain Research, 605, 1–8.

    CAS  Google Scholar 

  • Ohm, T.G., & Braak, H., 1989, Auditory brainstem nuclei in Alzheimer’s disease. Neuroscience Letters, 96. 60–63.

    Article  PubMed  CAS  Google Scholar 

  • Olton, D.S., Wible, C.G., Pang, K.. & Sakurai, Y., 1989, Hippocampal calls have mnemonic correlates as well as spatial ones. Psychobiology, 17, 228–229.

    Google Scholar 

  • Paganini-Hill, A., & Henderson, V.W., 1996, Estrogen replacement therapy and risk of Alzheimer disease. Archives of Internal Medicine. 156, 2213–2217.

    Google Scholar 

  • Parker, W.D., Jr., Filley, C.M., & Parks, J.K., 1990, Cytochrome oxidase deficiency in Alzheimer’s disease. Neurology, 40, 1302–1303.

    Article  PubMed  Google Scholar 

  • Parker, W.D., Jr., 1991, Cytochrome oxidase deficiency in Alzheimer’s disease. Annals of the New York Academy of Sciences, 640, 59–64.

    PubMed  Google Scholar 

  • Parker, W.D., Jr., Mahr, N.J., Filley, C.M., Parks, J.K., Hughes, M.A., Young, D.A., & Cullum, C.M., I994a, Reduced platelet cytochrome c oxidase activity in Alzheimer’s disease. Neurology, 44, 1086–1090.

    Google Scholar 

  • Parker, W.D., Jr., Parks, J., Filley, C.M., & Kleinschmidt-DeMasters, B.K., 1994b, Electron transport chain defects in Alzheimer’s disease brain. Neuoologi’, 44, 1090–1096.

    Google Scholar 

  • Parker. W.D., Jr., & Davis, R.E., 1997, Primary mitochondrial DNA defects as a causative event in Alzheimer’s disease. In M.F. Beal, N. Howell, & I. Bodis-Wollner (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases, pp. 319–334, New York: Wiley-Liss.

    Google Scholar 

  • Partridge, R.S., Monroe, S.M., Parks, J.K., Johnson, K., Parker, W.D., Jr., Eaton, G.R., & Eaton, S.S., 1994, Spin trapping of azidyl and hydroxyl radicals in azide-inhibited submitochondrial particles. Archives of Biochemistry and Biophysics, 310, 210–217.

    Article  PubMed  CAS  Google Scholar 

  • Pettegrew, J.W., Klunk, W.E., Panchalingam, K., Kanfer, J.N., & McClure, R.J., 1995, Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer’s disease. Neurobiology of Aging, 16, 1–4.

    Google Scholar 

  • Pettegrew, J.W., Klunk, W.E., Panchalingam, K., McClure. R.J., and Stanley, J.A., 1997, Magnetic resonance spectroscopic changes in Alzheimer’s disease. In J.C. de la Torre & V. Hachinski (Eds.), Cerebrovascular Patlologi: in AL - heimer’s Disease, pp. 282–306, New York: New York Academy of Sciences.

    Google Scholar 

  • Radi, R., Castro, L., Rodriguez, M., Cassina, A., & Thomson, L., 1997, Free radical damage to mitochondria. In M.F. Beal, N. Howell, and I. Bodis-Wollner (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases,pp. 57–90, New York: Wiley-Liss.

    Google Scholar 

  • Reiman, E.M., Caselli, R.J., Yun, L.S., Chen, K., Bandy, D., Minoshima, S.. Thibodeau, S.N., & Osborne, D., 1996, Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. New England Journal of Medicine, 334, 752–758.

    Article  PubMed  CAS  Google Scholar 

  • Richter, C., & Kass, G.E.N., 1991, Oxidative stress in mitochondria: its relationship to cellular Ca2+ homeostasis, cell death, proliferation, and differentiation. Chemico-Biological Interactions, 77, 1–23.

    Article  PubMed  CAS  Google Scholar 

  • Richter, C., 1995, Oxidative damage to mitochondrial DNA and its relationship with aging. International Journal of Biochemistry and Cell Biology, 27, 647–653.

    Article  PubMed  CAS  Google Scholar 

  • Saitoh, T., Sundsmo, M., Roch, J., Kimura, N., Cole, G., Schubert, D., Oltersdorf, T., & Schenk. D.B., 1989, Secreted form of amyloid protein precursor is involved in the growth regulation of fibroblasts. Cell. 58, 615–622.

    Google Scholar 

  • Sarnat, H.B., 1983, Muscle Pathology and Histochemistry, Chicago: American Society of Clinical Pathologists Press.

    Google Scholar 

  • Sayre, L.M., Zelasko, D.A., Harris, P.L., Perry, G., Salomon, R.G., & Smith. M.A., 1997, 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease. Journal of Neurochemistry, 68, 2092–2097.

    Google Scholar 

  • Schlaepfer, W.W., Lee, C., Lee, V., & Zimmerman, U.J., 1985, An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis. Journal of Neurochemistry. 44, 502–509.

    Article  PubMed  CAS  Google Scholar 

  • Seligman, A.M., Karnovsky, M.J., Wasserkrug, H.L., & Hanker, J.S., 1968, Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine, DAB, Journal of Cell Biology, 38, 1–14.

    Article  PubMed  CAS  Google Scholar 

  • Sherwin, B.B., 1997, Estrogen effects on cognition in menopausal women. Neurology, 48, 521 - S26

    Article  Google Scholar 

  • Shimohama, S., Suenaga, T., Araki, W., Yamaoaka, Y., Shimizu, K., & Kimura, J., 1991, Presence of calpain II immunoreactivity in senile plaques in Alzheimer’s disease. Brain Research, 558, 105–108.

    Article  PubMed  CAS  Google Scholar 

  • Siman, R., Card, J.P., & Davis, L.G., 1990, Proteolytic processing of B-amyloid precursor by calpain 1. Journal of Neuroscience, 10, 2400–2411.

    PubMed  CAS  Google Scholar 

  • Sinha, U.K., Hollen, K.M., Rodriguez, R., & Miller, C.A., 1993, Auditory system degeneration in Alzheimer’s disease. Neurology, 43, 779–785.

    Article  PubMed  CAS  Google Scholar 

  • Smith, M.A., Lawrence, S.M., Monnier, V.M., & Perry, G., 1995a, Radical ageing in Alzheimer’s disease. Trends in Neuroscience, 18, 172–176.

    Google Scholar 

  • Smith, M.A., Rudnicka-Nawrot, M., Richey, P.L., Prapotnik, D., Mulvihill, P., Miller, C.A., Sayre, L.M., & Perry, G., 1995b, Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer’s disease. Journal of Neurochemistry, 64, 2660–2666.

    Article  PubMed  CAS  Google Scholar 

  • Smith, M.A., Perry, G., Richey, P.L., Sayre, L.M., Anderson, V.E., Beal, M.F., & Kowall, N., 1996a, Oxidative damage in Alzheimer’s. Nature, 382, 120–121.

    Article  PubMed  CAS  Google Scholar 

  • Smith, M.A., Sayre, L., & Perry, G., 1996b, Is Alzheimer’s a disease of oxidative stress’? Alzheimer’s Disease Review, 1, 63–67.

    CAS  Google Scholar 

  • Smith, M.A., Richey-Harris, P.L., Sayre, L.M., Beckman, J.S., & Perry, G., 1997, Widespread peroxynitrite-mediated damage in Alzheimer’s disease. Journal of Neuroscience, 17, 2653–2657.

    PubMed  CAS  Google Scholar 

  • Sohal, R.S., 1997, Role of mitochondria and oxidative stress in the aging process. In M.F. Beal, N. Howell, and I. Bodis-Wollner (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases, pp. 91–108, New York: Wiley-Liss.

    Google Scholar 

  • Sokoloff, L., 1989, Circulation and energy metabolism of the brain. In G.J. Siegel, B.W. Agranoff, R.W. Albers, & P. Molinoff (Eds.), Basic Neurochemistry, pp. 471–495, Boston: Little Brown.

    Google Scholar 

  • Southorn, P.A., & Powis, G., 1988, Free radicals in medicine. Mayo Clinic Proceedings, 63, 381–408.

    Article  PubMed  CAS  Google Scholar 

  • Spagnoli, A., Lucca, U., Menasce, G., Bandera, L., Cizza, G., Forloni, G., Tettamanti, M., Frattura, L., Tiraboschi, P., & Comelli, M., 1991, Long-term acetyl-L-camitine treatment in Alzheimer’s disease. Neurology, 41, 1726–1732.

    Article  PubMed  CAS  Google Scholar 

  • Terwel, D., Prickaerts, J., Meng, F., & Jolles, J., 1995, Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine. European Journal of Pharmacology, 287, 65–71.

    Article  PubMed  CAS  Google Scholar 

  • Uchida, Y., Ihara, Y., & Tomonaga, M., 1988, Alzheimer’s disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats. Biochemical and Biophysical Research Communications, 150, 1263–1267.

    Article  PubMed  CAS  Google Scholar 

  • Van Hoesen, G.W., 1990, The dissection by Alzheimer’s disease of cortical and limbic neural systems relevant to memory. In J.L. McGaugh, N.M. Weinberger, and G. Lynch (Eds.), Brain Organization and Memory: Cells, Systems, and Circuits, pp. 234–261, New York: Oxford University Press.

    Google Scholar 

  • Van Zuylen, A.J., Bosman, G.J., Ruitenbeek, W., Van Kalmthout, P.J., & De Grip, W.J., 1992, No evidence for re- duced thrombocyte cytochrome oxidase activity in Alzheimer’s disease. Neurology 42, 1246–1247.

    Article  PubMed  Google Scholar 

  • Wharton, D.C., & Tzagoloff, A., 1967, Cytochrome oxidase from beef heart mitochondria. Methods of Enzymology, 10, 245–250.

    Article  CAS  Google Scholar 

  • Wikstrom, M., Krab, K., & Saraste, M., 1981, Cytochrome oxidase: A synthesis. New York: Academic Press.

    Google Scholar 

  • Wong-Riley, M.T.T., Merzenich, M.M., & Leake, P.A., 1978, Changes in endogenous reactivity to DAB induced by neuronal inactivity. Brain Research, 141, 185–192.

    Article  PubMed  CAS  Google Scholar 

  • Wong-Riley, M.T.T., 1979, Changes in the visual system of monocularly sutured or enucleated cats demonstrated with cytochrome oxidase histochemistry. Brain Research, 171, 11–28.

    Google Scholar 

  • Wong-Riley, M.T.T., & Riley, D.A., 1983, The effect of impulse blockage on cytochrome oxidase activity in the cat visual system. Brain Research, 261, 185–193.

    Article  PubMed  CAS  Google Scholar 

  • Wong-Riley, M.T.T., 1989, Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends in Neurosciences, 12, 94–101.

    Article  PubMed  CAS  Google Scholar 

  • Yan, S.D., Chen, X., Schmidt, A.M., Brett, J., Godman, G., Zou, Y.S., Scott, C.W., Caputo, C., Frappier, T., Smith, M.A., Perry, G., Yen, S.H., & Stern, D., 1994, Glycated tau protein in Alzheimer’s disease: a mechanism for induction of oxidant stress. Proceedings of the National Academy of Sciences, 91, 7787–7791.

    Article  CAS  Google Scholar 

  • Yan, S.D., Yan, S.F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M.A., Perry, G., Godman, G.C., Nawroth, P., Zweier, J.L., & Stern, D., 1995, Non-enzymatically glycated tau in Alzheimer’s disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nature Medicine, 1, 693–699.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Neuroscience and Department of Psychology, The University of Texas at Austin, Mezes 330, Austin, Texas, 78712, USA

    F. Gonzalez-Lima, J. Valla & L. Jorandby

Authors
  1. F. Gonzalez-Lima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Valla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Jorandby
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute for Neuroscience and Department of Psychology, The University of Texas at Austin, Mezes 330, 78712, Austin, Texas, USA

    F. Gonzalez-Lima

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gonzalez-Lima, F., Valla, J., Jorandby, L. (1998). Cytochrome Oxidase Inhibition In Alzheimer’s Disease. In: Gonzalez-Lima, F. (eds) Cytochrome Oxidase in Neuronal Metabolism and Alzheimer’s Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9936-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9936-1_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9938-5

  • Online ISBN: 978-1-4757-9936-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation